MRSA colonisation in patients admitted with hip fracture: implications for prevention of surgical site infection.
In a prospective study we assessed 440 patients, sequentially admitted to the trauma unit with hip fracture. Of the 403 who had a swab on admission, 5.2% (21/403) were found to be colonised with MRSA. Fifty two percent of MRSA colonised patients were admitted from their own home, 29% from residential homes and 19% from nursing homes. MRSA colonisation was found in 3.6% of patients admitted from their own home, 10.9% of residential home patients, and 17.4% of nursing home patients. A high proportion (80.9%) of colonised patients had been admitted to a hospital within the previous one year, and the high prevalence of previous hospitalisation among people from institutional care may explain the higher rates of MRSA carriage among these individuals. When a patient gives a history of hospitalisation within the previous year, it is clearly sensible to consider the use of an agent such as teicoplanin for perioperative prophylaxis.
Thyagarajan
David
D
Department of Trauma & Orthopaedics, University Hospital of Wales, Cardiff & Vale NHS Trust Heath, Heath, Cardiff, United Kingdom CF14 8BH. davidskt@yahoo.co.uk
Sunderamoorthy
Dakshinamurthy
D
Haridas
Samarthjoy
S
Beck
Sue
S
Praveen
Pathmanaban
P
Johansen
Anthony
A
D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D005260:Female; D006620:Hip Fractures / Q000382:microbiology / Q000601:surgery*; D006801:Humans; D008297:Male; D055624:Methicillin-Resistant Staphylococcus aureus; D010343:Patient Admission; D013203:Staphylococcal Infections / Q000453:epidemiology*; D013530:Surgical Wound Infection / Q000382:microbiology / Q000517:prevention & control*; D017334:Teicoplanin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D017334:Teicoplanin